David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
CALL
NewMarket
NEU
$8.61B
| $9.99M | 0.02% |
+20,900
| New | +$9.43M |
|
952
Dolby
DLB
$6.19B
| $9.96M | 0.02% |
261,114
+51,457
| +25% | +$2.05M |
|
953
Northern Trust
NTRS
$34.2B
| $9.94M | 0.02% |
142,763
+122,906
| +619% | +$8.39M |
|
954
PUT
Cardinal Health
CAH
$54B
| $9.93M | 0.02% |
110,000
-117,100
| -52% | -$10.1M |
|
955
PUT
RTX Corp
RTX
$282B
| $9.93M | 0.02% |
134,588
-91,050
| -40% | -$6.8M |
|
|
CAJ
956
DELISTED
Canon, Inc.
CAJ
| $9.92M | 0.02% |
280,384
-147,747
| -35% | -$4.83M |
|
|
GTLS
957
PUT
DELISTED
Chart Industries
GTLS
| $9.92M | 0.02% |
282,700
+10,000
| +4% | +$321K |
|
958
PUT
Devon Energy
DVN
$53.1B
| $9.9M | 0.02% |
164,100
-457,500
| -74% | -$27.9M |
|
959
PUT
Polaris
PII
$3.66B
| $9.88M | 0.02% |
70,000
-174,900
| -71% | -$25.8M |
|
960
ScottsMiracle-Gro
SMG
$3.53B
| $9.87M | 0.02% |
146,932
+15,052
| +11% | +$980K |
|
961
Chipotle Mexican Grill
CMG
$48.1B
| $9.82M | 0.02% |
754,600
+599,950
| +388% | +$8.19M |
|
962
Pediatrix Medical
MD
$2.16B
| $9.78M | 0.02% |
134,888
+112,816
| +511% | +$7.84M |
|
963
Equifax
EFX
$22.9B
| $9.75M | 0.01% |
104,826
+95,482
| +1,022% | +$8.47M |
|
964
Becton Dickinson
BDX
$52B
| $9.74M | 0.01% |
69,550
-65,548
| -49% | -$9.18M |
|
965
MarketAxess Holdings
MKTX
$5.72B
| $9.74M | 0.01% |
117,446
+28,703
| +32% | +$2.27M |
|
966
Textron
TXT
$14.1B
| $9.72M | 0.01% |
219,262
-117,297
| -35% | -$5.1M |
|
|
RPTP
967
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $9.68M | 0.01% |
890,030
+477,468
| +116% | +$4.87M |
|
968
CALL
Palo Alto Networks
PANW
$286B
| $9.67M | 0.01% |
397,200
-313,800
| -44% | -$7.03M |
|
969
The Mosaic Company
MOS
$7.63B
| $9.66M | 0.01% |
+209,654
| New | +$10.2M |
|
970
Orthofix Medical
OFIX
$399M
| $9.64M | 0.01% |
268,715
+5,557
| +2% | +$175K |
|
971
Hexcel
HXL
$7B
| $9.63M | 0.01% |
187,327
+126,653
| +209% | +$5.81M |
|
972
Kroger
KR
$36.2B
| $9.62M | 0.01% |
+250,842
| New | +$8.95M |
|
973
CALL
Starbucks
SBUX
$123B
| $9.58M | 0.01% |
202,400
+2,400
| +1% | +$108K |
|
974
CALL
Zillow
ZG
$8.53B
| $9.57M | 0.01% |
286,200
-272,400
| -49% | -$9.62M |
|
|
ESV
975
PUT
DELISTED
Ensco Rowan plc
ESV
| $9.57M | 0.01% |
113,525
+5,400
| +5% | +$569K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.